HealthKetamine-Based Antidepression Nasal Spray Gets FDA Thumbs Up The FDA announced on Tuesday that esketamine has been approved for people with treatment-resistant depression. The drug developed by Janssen Pharmaceuticals Inc. can offer quick relief from symptoms for patients living with the mood disorder.by Diane Samson
Healthy Living/WellnessLight Therapy Also Effective Treatment For All Depression Not Just Winter Bluesby Alyssa Navarro
Healthy Living/WellnessA single dose of antidepressant can alter how your brain worksby Christian Bautista
Vehicle‑to‑Home V2H Charging: A Practical Guide to Using Your EV as Home UPS and EV Battery Home Backup